MedPath

Cognitive Intervention With Go and Chess in Early and Subjective Cognitive Decline

Not Applicable
Recruiting
Conditions
Mild Cognitive Impairment
Subjective Cognitive Decline
Interventions
Other: Go classes
Other: Chess classes
Registration Number
NCT06281652
Lead Sponsor
University of Milano Bicocca
Brief Summary

The goal of this clinical trial\]is to evaluate if learning to play traditional board games could improve cognition in subjects with mild cognitive impairment and subjective cognitive decline. The main questions it aims to answer are:

* Do Go and Chess improve cognition?

* Is a game better than the other? Is the effect of both games on cognition synergistic?

* Do Go and Chess improve quality of life?

* Do Go and Chess improve mood?

* Do Go and Chess improve lifestyle?

Participants will be randomized to one of four groups:

* Group intervention with Go, once a week, for 12 weeks

* Group intervention with Chess, once a week, for 12 weeks

* Group intervention with Go and Chess, twice a week, for 12 weeks

* Control group

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
80
Inclusion Criteria
  • Diagnosis of mild cognitive impairment or subjective cognitive decline
  • Willingness to participate in the board games classes
  • Living within 20-minute driving distance from the center
  • Signed informed consent
Exclusion Criteria
  • Prior knowledge of the the game rules (in case the subject knows one of the two, they can be randomized to the other one)
  • Significant linguistic or sensory impairment (according to clinical judgment)
  • Significant behavioral or psychiatric disturbances (according to clinical judgment)
  • Significant medical comorbidities (according to clinical judgment)

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Go & Chess classesGo classesSubjects randomized to a group intervention with Go and Chess lessons twice a week for 12 weeks
Go & Chess classesChess classesSubjects randomized to a group intervention with Go and Chess lessons twice a week for 12 weeks
Chess classesChess classesSubjects randomized to a group intervention with Chess lessons once a week for 12 weeks
Go classesGo classesSubjects randomized to a group intervention with Go lessons once a week for 12 weeks
Primary Outcome Measures
NameTimeMethod
General cognition12 weeks

Differences in Montreal Cognitive Assessment between groups \[continuous scale, 0-30, higher scores indicate better performances\]

Secondary Outcome Measures
NameTimeMethod
Digit Span Backwards12 weeks

Differences in Digit Span Backwards between groups \[continuous scale, 0-9, higher scores indicate better performances\]

Semantic fluency12 weeks

Differences in Semantic fluency between groups \[continuous scale, min 0, max N/A, higher scores indicate better performances\]

Quality of life indicator12 weeks

Differences in WHO Quality of life (WHO-QoL) scale between groups \[continuous scale, min 0 max 100, higher scores indicate better quality of life\]

Digit Span Forward12 weeks

Differences in Digit Span Forward between groups \[continuous scale, 0-9, higher scores indicate better performances\]

Trail Making Test - part B12 weeks

Differences in Trail Making Test - part B between groups \[time to complete the task, min 0 seconds, max N/A, higher scores indicate worse performances\]

Trail Making Test - part A12 weeks

Differences in Trail Making Test - part A between groups \[time to complete the task, min 0 seconds, max N/A, higher scores indicate worse performances\]

Depression12 weeks

Differences in geriatric depression scale scale between groups \[continuous scale, min 0 max 15, higher scores indicate worse depression\]

Lifestyle12 weeks

Differences in simple lifestyle indicator questionnaire scale between groups \[continuous scale, min 0 max 10, higher scores indicate healthier lifestyle\]

Trial Locations

Locations (1)

Fondazione IRCCS San Gerardo dei Tintori

🇮🇹

Monza, Lombardia, Italy

© Copyright 2025. All Rights Reserved by MedPath